Home>About>People>External Advisory Board
Jeff Healey

External Advisory Board

Jeff Healey, MD, MSc, FRCP(C), FHRS

Jeff Healey is the Director of arrhythmia services and Associate Professor of Medicine at McMaster University. He is also a clinical trialist, and member of the Population Health Research Institute. Dr. Healey completed his clinical training in cardiology and electrophysiology at the University of Ottawa Heart Institute and completed his Master’s degree in health research methodology at McMaster University. 

Currently, Dr. Healey’s clinically activities involve both catheter ablation and pacemaker/ICD implantation.  His research involves the conduct of randomized clinical trials and large registries in the fields of atrial fibrillation and cardiac devices. Dr. Healey is the principal investigator and chair of the Canadian Stroke Prevention Intervention Network (CSPIN), a ten-year network grant funded by the CIHR, The Heart and Stroke Foundation of Canada and industry.  CSPIN will conduct a series of clinical trials related to atrial fibrillation and stroke prevention and will also support the development of new Canadian researchers in this field.  He is the past co-chair of the Canadian Cardiovascular Society’s Atrial Fibrillation Guidelines Committee and past chair of the Cardiac Care Network of Ontario’s Heart Rhythm Working group. 

Dr. Healey has published over 185 manuscripts, including more than 60 in the past 3 years. Dr. Healey was the lead author of the ASSERT trial, which was published in the New England Journal of Medicine in 2012 and demonstrated the increased stroke risk associated with sub-clinical atrial fibrillation detected by pacemakers.  Thomson-Reuters recognized ASSERT as the 38th most-cited scientific publication in 2012 (#16 in Medicine).  He was also the lead author of the SIMPLE trial, published in the Lancet in 2015, which demonstrated that implantable defibrillators could be safely inserted without performing intra-operative defibrillation testing.  The RELY AF Registry is a 15,000-patient worldwide registry, examining the causes, treatment and outcomes in patients with atrial fibrillation.